Form 8-K - Current report:
SEC Accession No. 0001140361-24-031563
Filing Date
2024-06-27
Accepted
2024-06-27 16:09:40
Documents
55
Period of Report
2024-06-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20031755x2_8k.htm   iXBRL 8-K 31073
2 EXHIBIT 99.1 ny20031755x2_ex99-1.htm EX-99.1 19624
3 EXHIBIT 99.2 ny20031755x2_ex99-2.htm EX-99.2 76329
7 ny20031755x2_ex99-2img001.jpg GRAPHIC 220598
8 ny20031755x2_ex99-2img002.jpg GRAPHIC 128153
9 ny20031755x2_ex99-2img003.jpg GRAPHIC 280309
10 ny20031755x2_ex99-2img004.jpg GRAPHIC 227657
11 ny20031755x2_ex99-2img005.jpg GRAPHIC 204696
12 ny20031755x2_ex99-2img006.jpg GRAPHIC 188544
13 ny20031755x2_ex99-2img007.jpg GRAPHIC 177536
14 ny20031755x2_ex99-2img008.jpg GRAPHIC 227436
15 ny20031755x2_ex99-2img009.jpg GRAPHIC 281687
16 ny20031755x2_ex99-2img010.jpg GRAPHIC 247865
17 ny20031755x2_ex99-2img011.jpg GRAPHIC 155420
18 ny20031755x2_ex99-2img012.jpg GRAPHIC 164380
19 ny20031755x2_ex99-2img013.jpg GRAPHIC 183885
20 ny20031755x2_ex99-2img014.jpg GRAPHIC 219120
21 ny20031755x2_ex99-2img015.jpg GRAPHIC 253868
22 ny20031755x2_ex99-2img016.jpg GRAPHIC 195912
23 ny20031755x2_ex99-2img017.jpg GRAPHIC 166045
24 ny20031755x2_ex99-2img018.jpg GRAPHIC 149961
25 ny20031755x2_ex99-2img019.jpg GRAPHIC 226805
26 ny20031755x2_ex99-2img020.jpg GRAPHIC 142857
27 ny20031755x2_ex99-2img021.jpg GRAPHIC 165505
28 ny20031755x2_ex99-2img022.jpg GRAPHIC 165048
29 ny20031755x2_ex99-2img023.jpg GRAPHIC 173333
30 ny20031755x2_ex99-2img024.jpg GRAPHIC 154995
31 ny20031755x2_ex99-2img025.jpg GRAPHIC 220728
32 ny20031755x2_ex99-2img026.jpg GRAPHIC 209238
33 ny20031755x2_ex99-2img027.jpg GRAPHIC 158958
34 ny20031755x2_ex99-2img028.jpg GRAPHIC 152349
35 ny20031755x2_ex99-2img029.jpg GRAPHIC 164594
36 ny20031755x2_ex99-2img030.jpg GRAPHIC 172195
37 ny20031755x2_ex99-2img031.jpg GRAPHIC 147644
38 ny20031755x2_ex99-2img032.jpg GRAPHIC 172863
39 ny20031755x2_ex99-2img033.jpg GRAPHIC 135308
40 ny20031755x2_ex99-2img034.jpg GRAPHIC 140131
41 ny20031755x2_ex99-2img035.jpg GRAPHIC 133224
42 ny20031755x2_ex99-2img036.jpg GRAPHIC 99071
43 ny20031755x2_ex99-2img037.jpg GRAPHIC 192500
44 ny20031755x2_ex99-2img038.jpg GRAPHIC 191563
45 ny20031755x2_ex99-2img039.jpg GRAPHIC 118445
46 ny20031755x2_ex99-2img040.jpg GRAPHIC 220840
  Complete submission text file 0001140361-24-031563.txt   10395740

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eltx-20240627.xsd EX-101.SCH 3859
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltx-20240627_lab.xml EX-101.LAB 22690
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltx-20240627_pre.xml EX-101.PRE 16548
59 EXTRACTED XBRL INSTANCE DOCUMENT ny20031755x2_8k_htm.xml XML 4225
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 241079243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)